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Abstract
Background: Currently, food supplements to improve age-related dementia are required. Therefore, we aimed to
determine the effect of the combined extract of Cyperus rotundus and Zingiber officinale (CP1) on the improvement
of age-related dementia in rats with AF64A-induced memory deficits.
Methods: Male Wistar rats weighing 180-200 g were orally given CP1 at doses of 100, 200 and 300 mg.kg-1 BW for
a period of 14 days after bilateral intracerebroventricular administration of AF64A. Spatial memory was assessed in
all rats every 7 days throughout the 14 day-experimental period. At the end of the study, neuronal density,
acetylcholinesterase (AChE) activity, oxidative stress status and the activation of MAPK cascades in the hippocampus
were determined.
Results: Enhanced memory, increased neuronal density, decreased AChE activity and decreased oxidative stress
status together with activated pERK1/2 were observed in the hippocampus of CP1-treated rats. These results
suggested that CP1 might improve memory via enhanced cholinergic function and decreased neurodegeneration
and oxidative stress.
Conclusions: CP1 is a potential novel food supplement for dementia. However, further investigations on the
subchronic toxicity of CP1 and drug interactions are required.
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Background
The importance of dementia, a condition of memory
and intellectual impairment, is increasing along with the
increase in the older population. The total number of
people with dementia worldwide in 2010 was estimated
at 35.6 million and is projected to nearly double every
20 years to 65.7 million in 2030 and 115.4 million in
2050. This condition produces a great impact on the
healthcare budget and social care [1]. Therefore, it has
gained much attention.
Dementia, especially age-related dementia, is associated
with many factors including forebrain and hippocampal
atrophy [2, 3], acetylcholine (ACh) reduction [4], cholinergic
hypofunction [5, 6], basal forebrain cholinergic neuron de-
generation, neurotrophic signaling reduction [6] and excess
oxidative stress [7]. Based on the crucial role of hypocholi-
nergic function on dementia mentioned earlier, current anti-
dementia drugs are targeted at the enhancement of choliner-
gic function. However, the current therapeutic efficacy is still
limited, and adverse effects are commonly experienced [8].
Therefore, protection from dementia is required.
Medicinal plants have long been used for longevity
promotion, neuroprotection and memory enhancement in
traditional folklore. Both Cyperus rotundus, a plant in the
Cyperaceae family, and Zingiber officinale, a plant in the
Zingiberaceae family, are both reputed to exhibit longevity
promotion. The phytochemical constituents of C.
rotundus and Z. officinale have been studied extensively.
C. rotundus contains quercetin, kaempferol, alkaloids,
flavonoids, tannins, starch, glycosides, chalcones, gallic
acid and p-coumaric acid [9, 10]. Z. officinale includes
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gingerol, paradols, and shogaol [11, 12]. Scientific data
have demonstrated that C. rotundus and Z. officinale pos-
sess antioxidant, acetylcholinesterase inhibitory (AChEI),
neuroprotective and memory-enhancing effects [13–18].
Based on the crucial role of hypocholinergic function and
oxidative stress in dementia, the beneficial effect of both
plants in dementia is the focus of this study. To optimize
the benefit of the plant extracts, the positive modulation
effect from the interaction of both plants has gained
attention. We hypothesized that the combination of the
extracts from C. rotundus and Z. officinale (CP1) could
protect against age-related dementia. To test this hypoth-
esis, we aimed to determine the antioxidant and AChEI
effects of CP1. In addition, an in vivo study was also car-
ried out to determine the neuroprotective effect of CP1
against age-related dementia in an animal model induced
by a cholinotoxin, AF64A.
Methods
Plant collection and extract preparation
The aerial part of C. rotundus and the rhizome of Z.
officinale were harvested from Khon Kaen province,
Thailand from September – November 2012. C. rotun-
dus was authenticated by Associate Professor Panee
Sirisa-ard, from the Faculty of Pharmacy, Chiang Mai
University, Thailand (voucher specimen No. 023159),
and Z. officinale was authenticated by the National
Museum of THAI Traditional Medicine, Thailand (vou-
cher specimen No. 0002402). The plant materials were
prepared as 95% alcoholic extracts. The percent yield of
the C. rotundus and Z. officinale extracts were 7.41%
and 10.48%, respectively. Based on our pilot in vitro
study, a 1:5 ratio of C. rotundus to Z. officinale was
found to exhibit the highest potential to protect against
neurodegeneration induced by oxidative stress and in-
creased the levels of neurotransmitters such as acetyl-
choline and dopamine, which play important roles in
learning and memory (see Additional file 1: Table S1).
Therefore, this ratio was selected for developing a novel
neuroprotectant “CP1”. To control the quality of the
developed neuroprotectant, the finger print of CP1 and
the concentrations of gingerol and quercetin, the major
chemical constituents of Z. officinale and C. rotundus
that were previously reported to produce neuroprotec-
tion and memory enhancement [19, 20], were analyzed
using high-performance liquid chromatography. The
HPLC-UV analysis indicated that CP1 comprises gin-
gerol, quercetin and several other unidentified peaks
(See Additional file 1: Figure S1 and S2). In addition,
semi-quantitative analysis revealed that the concentra-
tion of gingerol and quercetin was 65 and 7 mg/mL,
respectively. The combined extract was kept at -20 °C in
a dark bottle until use.
Determination of antioxidant activity
Radical scavenging activity of 2,2-diphenyl-1-picrylhydra-
zyl (DPPH) radical of the combined extract of Z. officinale
and C. rotundus (CP1) was determined spectrophotomet-
rically [21]. The principle of the assay is based on the
color change of the DPPH solution from purple to yellow
when the radical is quenched by the antioxidant. In brief,
2.96 mL of a 0.1 mM solution of DPPH in methanol was
incubated with 40 μL of various concentrations of extract
(1.0, 2.0, 5.0, 10.0, 20.0, 25.0 mg/mL) at room temperature
for 30 min. The decrease in DPPH radicals was evaluated
by the optical density measurement at 515 nm. The stable
free radical scavenging capacity is presented as the
percentage of inhibition of DPPH radicals calculated
according to the following equation: % inhibition of
DPPH= (Abs control-Abs sample/Abs control) × 100
Determination of antioxidant activity by ferric reducing
antioxidant power (FRAP)
The ferric reducing antioxidant power assay was performed
according to the procedure previously described [22] with
some modifications. Briefly, the working FRAP reagent was
mixed with 25 mL of 300 mM acetate buffer (3.1 g
C2H3NaO2 · 3H2O and 16 mL C2H4O2), pH 3.6, 2.5 mL of
10 mM tripyridyltriazine (TPTZ) solution in 40 mM HCl,
and 2.5 mL of 20 mM FeCl3 · 6H2O solution. Then, 1.8 mL
of the FRAP solution was mixed with the CP1 extract
(10 μL) in 1 mL distilled water. The absorbance of the reac-
tion mixture at 593 nm was measured spectrophotometric-
ally after incubation at 37 °C for 10 min. The results were
expressed as μM ascorbic acid/100 g fresh weight.
Determination of acetylcholinesterase (AChE) inhibition
AChE inhibitory activity was measured by using Ellman's
colorimetric method [23]. Briefly, in 96-well plates, 25 μL
of 15 mM ATCI, 75 μL of 3 mM DTNB and 50 μL of
50 mM Tris–HCl, pH 8.0, containing 0.1% bovine serum
albumin (BSA), and 25 μL of the tested phytochemicals
were added. The absorbance was measured at 405 nm
after a 5-min incubation at room temperature. Then,
25 μL of 0.22 U.ml-1 of AChE was added and incubated
for 5 min at room temperature, and the absorbance was
measured at 412 nm. Acetylcholinesterase (5–1,000 μM)
was used as a reference standard. The percentage
inhibition was calculated using the following equation:
Inhibition (%) = 1 – (Asample/Acontrol) × 100, where Asample
is the absorbance of the sample extracts, and Acontrol is
the absorbance of the blank (50% aqueous methanol in
buffer).
In addition to the in vitro assay of AChE mentioned earl-
ier, we also determined AChE activity in the hippocampal
homogenate. In brief, the hippocampus was isolated and
homogenized in ice-cold 0.1 M phosphate-buffered saline
(pH 8.0). The homogenate was centrifuged at 1,000 g for
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10 min at 4 °C, and the supernatant was used as the source
of the enzyme in the AChE assay. AChE activity in hippo-
campus was evaluated using Ellman's method with slight
modifications [24].
Animals
Eight-week-old male Wistar rats weighing 180-220 g were
used as experimental animals. They were derived from the
National Laboratory Animal Center, Salaya, Nakorn
Pathom. They were housed 6 per cage, maintained in a 12:
12 light: dark cycle, and given a standard pellet diet and
water ad libitum. The experiments were performed to
minimize animal suffering, and the experimental protocols
were approved by the Animal Ethics Committee of Khon
Kaen University, based on the Ethics of Animal Experi-
mentation of National Research Council of Thailand
(Confirmation No. AEKKU 41/2554).
AF64A preparation
The preparation of AF64A was performed according to
the method described by Hanin. In brief, an aqueous solu-
tion of acetylethylcholine mustard HCl (Sigma–Aldrich
Co., USA) was adjusted to pH 11.3 with NaOH and stirred
for 30 min. Then, the pH of the solution was adjusted to
pH 7.4 with the gradual addition of HCl and stirred for
60 min at room temperature. The amount of AF64A was
then adjusted to 2 nmol/2 μL. Artificial cerebrospinal fluid
(ACSF) or vehicle of AF64A was distilled water, which
was prepared in the same manner as AF64A.
Surgical procedures
Sodium pentobarbital (Jagsonpal Pharmaceuticals LTD,
Haryana, India) at a dose of 60 mg/kg BW was adminis-
tered to the animals via the intraperitoneal route to
induce anesthesia. The memory deficit was induced by
the bilateral intracerebroventricular (i.c.v.) injection of
AF64A (2 nmol/2 μL, 2 μL/side). Burr holes were made
in the skull according to the following stereotaxic coor-
dinates; posterior 0.8 mm, lateral ±1.5 mm, and ventral
(from dura) 3.6 mm. AF64A was perfused via a 30-gauge
needle that was inserted through the burr holes, and the
perfusion rate was 1.0 μL/min. After being left at the in-
jection site for 5 min, the needle was slowly withdrawn.
The animals were allowed to recover from anesthesia
and then placed in their cages.
Experimental protocol
All rats were randomly assigned to 7 groups as follows:
Group I Vehicle + ACSF; rats were orally given
propylene glycol, which served as the vehicle to
suspend the combined extract of CP1, once daily for
14 days after the administration of ACSF.
Group II Vehicle + AF64A; rats were orally treated with
propylene glycol once daily for a period of 14 days after
the administration of AF64A.
Group III Donepezil + AF64A; the animals were orally
treated with donepezil (Aricept) (1 mg/kg BW), a
cholinesterase inhibitor that is widely used as a
standard drug for dementia treatment [25], once daily
for a period of 14 days after the administration of
AF64A.
Group IV Vitamin C + AF64A; the animals were orally
treated with vitamin C (250 mg/kg BW), a standard
antioxidant that was previously reported to enhance
memory and to attenuate neurodegeneration [25], once
daily for a period of 14 days after the administration of
AF64A.
Group V-VII CP1 + AF64A; rats were treated with CP1
at doses of 100, 200 and 300 mg.kg-1 BW for a period
of 14 days after the administration of AF64A.
Rats in all groups were orally given the assigned
substances for a period of 14 days after the bilateral intra-
cerebroventricular administration of AF64A. A memory
assessment was performed every 7 days throughout the
14-day study period, whereas the measurements of the
malondialdehyde (MDA) level and the activity of super-
oxide dismutase (SOD), catalase (CAT), glutathione
peroxidase (GSH-Px) and acetylcholinesterase (AChE) in
the hippocampus were performed at the end of study.
Moreover, the density of the surviving neurons in
various subregions of the hippocampus, including
CA1, CA2, CA3 and the dentate gyrus, was also
determined.
Determination of spatial memory
Spatial memory was evaluated using the Morris water
maze test. Rats were subjected to a metal pool (170 cm in
diameter × 58 cm height) filled with tap water (25 °C,
40 cm deep). This pool comprised 4 quadrants including a
northeast, southeast, southwest, and northwest quadrant.
The water surface was covered with non-toxic milk. The
removable platform was immersed below the water level
at the center of one quadrant. All rats were trained to
memorize the location of the invisible platform by forming
the association of their location and the location of the
platform using external cues. The time that the animal
took to reach the top of the hidden platform was recorded
as the escape latency or acquisition time. To determine
the capability of the animals to retrieve and retain infor-
mation, the platform was removed 24 hr later, and the rats
were re-exposed to the same condition, except that the
platform was removed. The time that each animal spent
in the region that previously contained the platform was
recorded as the retention time.
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Determination of the density of surviving neurons in the
hippocampus
Histological study
Following induction of anesthesia with sodium pentobar-
bital (60 mg/kg BW), brain fixation was carried out by
transcardial perfusion with a fixative solution containing
4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.3.
After the perfusion, the brain was removed and stored
overnight in the fixative solution that was used in the
perfusion, infiltrated with 30% sucrose solution and kept
at 4 ° C. The specimens were frozen rapidly, and 10-μM
thick coronal sections were prepared using a cryostat.
All sections were rinsed in phosphate buffer and placed
on slides coated with a 0.01% aqueous solution of a high
molecular weight poly L-lysine.
Morphological analysis
Five coronal sections from each rat in each group were
studied quantitatively. The evaluation of the neuronal
density in the hippocampus was performed under a light
microscope at 40x magnification. The observer was
blind to the treatment at the time of analysis. Viable
stained neurons were identified on the basis of a stained
soma with at least two visible processes. Counts were
made in five adjacent fields, and the mean number was
calculated and expressed as density of neurons per
255 μm2.
Determination of oxidative stress markers
Rats were perfused with a cold saline solution to get rid
of the blood from the brain tissue. Then, the hippocam-
pus was isolated and prepared as a hippocampal hom-
ogenate, and the determination of the oxidative stress
markers was performed. The malondialdehyde (MDA)
level was indirectly estimated by determining the accu-
mulation of thiobarbituric acid reactive substances
(TBARS) [26]. To determine the activity of antioxidant
enzymes, including superoxide dismutase (SOD), cata-
lase (CAT) and glutathione peroxidase (GSH-Px), the
hippocampus of each rat was weighed and homogenized
with a buffer consisting of 10 mM sucrose, 10 mM
Tris–HCl and 0.1 mM EDTA (pH 7.4). Then, a hippo-
campal homogenate was centrifuged at 3000 g at 4 °C
for 15 min. The supernatant was separated and used for
bioassays. The activity of SOD was determined using a
xanthine/xanthine oxidase system as the source of
superoxide radical production and the subsequent meas-
urement of cytochrome c as a scavenger of the radicals.
Optical density was measured using a spectrometer
(UV-1601, Shimadzu) at 550 nm [27]. SOD activity was
presented as units per milligram of protein (U mg-1
protein). One unit of enzyme activity was defined as the
quantity of SOD required to inhibit the reduction rate of
cytochrome c by 50%. CAT activity in the supernatant
was measured by recording the reduction rate of H2O2
absorbance at 240 nm [28]. The activity of CAT was
expressed as μmol H2O2.min
-1mg-1 protein. GSH-Px
was determined using t-butyl hydroperoxide as a sub-
strate. The optical density was spectrophotometrically
recorded at 340 nm and expressed as U mg-1protein
[29]. One unit of the enzyme was defined as one micro-
mole (μmol) of reduced nicotinamide adenine dinucleo-
tide phosphate (NADPH) oxidized per minute.
Western blot analysis
The hippocampus was removed and rapidly frozen at
-80 °C. The frozen tissue samples were homogenized in
ice-cold RIPA buffer with protease inhibitors. The
dissolved proteins were collected after centrifugation at
10,000 g for 30 min, and the supernatant was then
collected. Protein concentration was determined using
the NANOdrop Spectrophotometers. Equal amounts of
protein (35 μg) were separated by SDS-PAGE (10% SDS-
polyacrylamide gel electrophoresis) and transferred to a
polyvinylidene difluoride (PVDF) membrane (Bio-Rad
Laboratories, Hercules, CA). After transferring to the
membrane, the blots were incubated in a blocking buffer
(5% skim milk in Tris-buffer saline with 0.05% Tween-
20) for 1 hr at room temperature and incubated over-
night with antibodies against either phospho-ERK1/2
(1:1,000, Cell Signaling Cell Signaling Technology, Inc.,
Boston, MA, USA) or total ERK1/2 (1:1,000, Cell
Signaling Cell Signaling Technology, Inc., Boston, MA,
USA). After incubation, the membrane was subjected to
several washing steps. An HRP-linked secondary
antibody (1:2,000) was incubated with the membrane for
1 hr at room temperature, and signals were visualized by
chemiluminescence using an ECL kit (Pierce,
ThermoScientific). Images were evaluated by Image-
Quant LAS 4000, GE Healthcare. Band densities were
quantified with ImageQuant TL (IQTL) software, GE
healthcare [30].
Statistical analysis
Data were expressed as the means ± S.E.M. and analyzed
statistically by one-way ANOVA, followed by a post hoc
(LSD) test. The results were considered statistically sig-
nificant at a p-value < 0.05.
Results
Antioxidant activity and acetylcholinesterase (AChE)
inhibition of CP1
In the first part of this study, we determined and compared
the antioxidant effect of C. rotundus, Z. officinale and the
combined extract of C. rotundus and Z. officinale (CP1) by
using DPPH and FRAP assays. In addition, acetylcholin-
esterase (AChE) inhibition was also determined using
Ellman's colorimetric method. The results are shown in
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Table 1. Interestingly, our data clearly demonstrated that
the combination of the C. rotundus and Z. officinale
extracts (CP1) had a lower IC50 of FRAP (1.743 ±
0.003 mg/ml), DPPH (1.008 ± 0.001 mg/ml) and AChEI
(0.100 ± 0.103 mg/ml) than those of the C. rotundus or Z.
officinale extracts.
Effect of CP1 on spatial memory
In this part, we mimicked the memory impairment con-
dition observed in age-related dementia in humans by
inducing a hypocholinergic condition via the bilateral
administration of AF64A, a cholinotoxin, into the lateral
ventricles. Figure 1a and b showed that vehicle + ACSF
showed no significant changes in both escape latency
and retention time. Our data showed that the adminis-
tration of AF64A significantly enhanced escape latency
(p-value < .001 for all compared to the vehicle + ACSF
group) but decreased the retention time (p-value < .001
compared to the vehicle + ACSF group) on both the 7th
and 14th day. Both donepezil and vitamin C treatments
significantly mitigated the enhanced escape latency in-
duced by AF64A (p-value < .001 compared to the vehicle
+ AF64A group). Donepezil also mitigated the decreased
retention time induced by AF64A both at 7 and 14 days
of treatment (p-value < .05 and .001, respectively, com-
pared to the vehicle + ACSF group). Ascorbic acid only
mitigated the decreased retention time at 14 days of
treatment (p-value < .001 compared to the vehicle +
ACSF group). Interestingly, all doses of CP1 (100, 200
and 300 mg.kg-1) significantly mitigated the enhanced
escape latency at 7 (p-value < .001, .01 and .001, respect-
ively, compared to the vehicle + AF64A group) and
14 days of treatment (p-value < .01, .001 and .01, respect-
ively, compared to the vehicle + AF64A group). In
addition, CP1 at all doses used in this study also miti-
gated the decreased retention time induced by AF64A at
14 days of treatment (p-value < .001 for all compared to
the vehicle + AF64A group).
Table 1 FRAP, DPPH and AChEI activities of Zingiber officinale, Cyperus rotundus and CP1
Tested substance FRAP IC50 mg/ml DPPH IC50 mg/ml AChEI IC50 mg/ml
Zingiber officinale 6.724 ± 0.005 2.086 ± 0.002 2.422 ± 0.133
Cyperus rotundus 8.822 ± 0.004 1.041 ± 0.001 0.382 ± 0.104
CP1 1.743 ± 0.003 1.008 ± 0.001 0.100 ± 0.103
Fig. 1 The effect of CP1, the combination extract of C.rotundus and Z.officinale, on spatial memory a effect of CP1 on escape latency b effect of
CP1 on retention time (n = 8/ group) ***p-value < .001; compared to vehicle plus ACSF group; #,##,###p-value < .05, .01 and .001 respectively;
compared to vehicle plus AF64A group
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Effect of CP1 on hippocampal neurodegeneration
Figure 2 (see Additional file 1: Figure S3) shows the effect
of CP1 on neuronal density in the hippocampus. The
results showed that AF64A significantly decreased neuronal
density in the CA1, CA2, CA3 and dentate gyrus (p-value
< .001 for all compared to the vehicle + ACSF group). Rats
subjected to AF64A that received donepezil showed a
significant elevation in neuronal density only in the CA1,
CA2, CA3 and dentate gyrus (p-value < .01, .05, .05, .01,
respectively, compared to the vehicle + AF64A group). In
addition, vitamin C significantly enhanced the neuronal
density in the CA2 and CA3 in rats subjected to AF64A
treatment (p-value < .01 and .01, respectively, compared to
the vehicle + AF64A group). Interestingly, CP1 at a low
concentration (100 mg/kg) significantly attenuated the
reduction in the neuronal density in the CA1 (p-value < .05
compared to the vehicle + AF64A group) in rats that
received AF64A. An enhanced neuronal density in the CA2
and dentate gyrus was observed in rats subjected to AF64A
that received CP1 at doses of 200 and 300 mg.kg-1 BW
Fig. 2 The effect of CP1 on neuron density in various subregions of hippocampus including CA1, CA2, CA3 and dentate gyrus. a Average density
of neurons in CA1, CA2, CA3 and dentate gyrus b Photograph of neuron density in (1) CA1, (2) CA2, (3) CA3 and (4) dentate gyrus. (n = 8/group)
***p-value < .001; compared to vehicle + ACSF group. #, ##, ###p-value < .05, .01 and .001 respectively; compared to vehicle + AF64A group
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(p-value < .05 compared to the vehicle + AF64A group).
No significant changes were observed in the CA3.
Effect of CP1 on oxidative stress markers
The effects of CP1 on oxidative stress markers, including
the level of MDA and the activity of SOD, CAT and GSH-
Px in the hippocampus, were also evaluated. The results
are shown in Table 2. AF64A injection was demonstrated
to significantly increase the MDA level (p < .001 compared
to the vehicle + ACSF group) but decrease the activity of
SOD, CAT and GSH-Px (p < .001 for all compared to the
vehicle + ACSF group). The elevation in the MDA level in
the hippocampus induced by AF64A was mitigated by
donepezil, vitamin C and all doses of CP1 (p-value < .01,
.05, .05, .01 and .05, respectively, compared to the vehicle
+ AF64A group). Increased CAT activity was also ob-
served in rats subjected to AF64A that received donepezil,
vitamin C and all doses of CP1 (p-value < .01, .01, .05, .01.
01, respectively, compared to the vehicle + AF64A group).
All treatments mentioned earlier failed to modulate the
reduction in GSH-Px induced by AF64A.
Effect of CP1 on acetylcholinesterase (AChE) activity
The effect of CP1 on cholinergic function was evaluated
indirectly by using the activity of AChE as an indirect
indicator reflecting the available acetylcholine in the
hippocampus. The results are shown in Fig. 3. Rats exposed
to AF64A showed an elevation in AChE (p-value < .001
compared to the vehicle + ACSF group). However, this
change was reversed by donepezil, vitamin C and all doses
of CP1 (p-value < .05, .05, .05, .01 and .01, respectively,
compared to the vehicle + AF64A group).
Effect of CP1 on ERK1/2 activation
Since the ERK cascade plays an important role in synap-
tic plasticity, long-term potentiation and cell survival,
the effect of CP1 on ERK1/2 in the hippocampus was
also assessed. The results are shown in Fig. 4. AF64A in-
jection was found to significantly decrease phosphoryl-
ation of ERK1/2 (p-value < .001 compared to the vehicle
+ ACSF group). Interestingly, enhanced phosphorylation
of ERK1/2 was observed in the AF64A-treated rats that
received donepezil and those that received medium and
high doses of CP1 (p-value < .001, .05 and .01, respect-
ively, compared to the vehicle + AF64A group). No sig-
nificant change was observed in the AF64A-treated rats
that received either vitamin C or low doses of CP1.
Discussion
Medicinal plants have long been used for treating various
ailments either as single plants or as polyherbal recipes.
However, the polyherbal recipes have been more widely
used than the single plants based on the concept that the
synergistic effect of multiple plants can provide more
beneficial effects [31]. However, less scientific evidence is
available. In this study, we have clearly demonstrated that
CP1, the combined extract of C. rotundus and Z. offici-
nale, showed a lower IC50 of both the antioxidant effect
via DPPH and the AChEI effect. Therefore, our results
confirmed the hypothesis that the interaction of both me-
dicinal plants mentioned earlier could provide a greater
benefit. This was also in agreement with other studies that
have demonstrated the beneficial effect of the combined
extract [32–34].
The current results also demonstrated that CP1 signifi-
cantly increased spatial memory, enhanced cholinergic
function and decreased oxidative stress in the hippocampus.
The current data revealed that CP1 at all doses in this study
increased CAT activity, and the low dose of CP1 increased
SOD activity. Therefore, the increase in CAT activity with
SOD activity might involve the reduction of oxidative
damage [35].
In addition, CP1 also significantly enhanced the density
of neurons in the CA1, CA2 and dentate gyrus and in-
creased pERK1/2 levels in these same areas. ERK1/2, a sub-
class of mitogen-activated protein (MAP) kinases, has been
reported to play a pivotal role in neurodegeneration via the
mitochondrial apoptotic mechanism [36–38]. Neurodegen-
eration in the hippocampus, an important area for learning
and memory, is associated with memory deficits [39, 40].
Therefore, the memory-enhancing effect of CP1 may occur
partly via decreased oxidative stress by enhancing the activ-
ity of antioxidant enzymes in the hippocampus, which, in
Table 2 Effect of CP1 on the oxidative stress markers in hippocampus
Group MDA (nmol/mg · protein) SOD (unit/mg · protein) GSH-Px (unit/mg · protein) CAT (unit/mg · protein)
Vehicle + ACSF 0.0008 ± 0.0002### 3.3230 ± 0.1195### 0.0829 ± 0.0155 1 09.2071 ± 1.5467###
Vehicle + AF64A 0.0021 ± 0.0005*** 2.1633 ± 0.1244*** 0.0518 ± 0.0163 84.6617 ± 2.5905***
Donepezil + AF64A 0.0011 ± 0.0001## 2.9833 ± 0.3891## 0.0743 ± 0.0185 106.4200 ± 5.6561##
Vitamin C + AF64A 0.0011 ± 0.0001# 3.1532 ± 0.1500### 0.0870 ± 0.0095 106.8167 ± 3.6787##
CP1 100 mg/kgBW + AF64A 0.0013 ± 0.0002# 2.9210 ± 0.2465## 0.0705 ± 0.0235 101.3417 ± 6.1163#
CP1 200 mg/kgBW + AF64A 0.0011 ± 0.0001## 2.4226 ± 0.0834*** 0.0624 ± 0.0096 105.8271 ± 3.6703##
CP1 300 mg/kgBW + AF64A 0.0015 ± 0.0001# 2.3510 ± 0.0531*** 0.0612 ± 0.0088 102.3483 ± 5.4788##
*, ***p-value < .05 and.001 respectively; compared to vehicle + ACSF group. #, ##, ###p-value < .05, .01 and .001 respectively; compared to vehcle + AF64A group)
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turn, could induce an increase in pERK1/2 [41], giving rise
to an increased neuronal density in the CA1, CA2 and
dentate gyrus, leading to improvements in the encoding,
retrieval and consolidation processes resulting in enhanced
spatial memory [25]. Although the decreased oxidative
stress could increase the phosphorylation of ERK1/2, result-
ing in an anti-apoptotic effect and leading to enhanced
neuronal density in the hippocampus, no close relationship
between the increase in pERK1/2 and the decrease in oxi-
dative stress was observed, especially at the low concentra-
tion of CP1. Since decreased oxidative stress in rats with
AF64A–induced memory deficits can increase the neuronal
density in the hippocampus and can improve memory im-
pairment [42, 43], we suggested that the antioxidant effect
of CP1 might decrease oxidative stress status in the hippo-
campus, which in turn would decrease neurodegeneration
induced by the attack of free radicals, resulting in increased
neuronal density in this area. In addition, the activation of
ERK1/2 gives rise to the phosphorylation of ERK1/2, which
in turn plays an important role in the function of acetylcho-
line via the nicotinic receptor [44]. Therefore, it is also pos-
sible that CP1 at all doses used in this study may suppress
AChE, leading to an increase in the available acetylcholine
(ACh), which, in turn, may bind to the nicotinic receptor,
resulting in the activation and phosphorylation of ERK1/2
and finally leading to improved spatial memory. These ef-
fects have been shown in Fig. 5.
Our results also showed differential vulnerability to
CP1. The CA3 region showed less vulnerability among
the various subregions assessed in this study. The pos-
sible explanation may be due to differences in the distri-
bution of signal molecules and growth factors that play
important roles in cell survival [44].
Our data failed to show dose-dependent effects. The
possible explanation might be related to the masking ef-
fect of non-active ingredients. In addition, the relation-
ship between the concentration of CP1 and the observed
parameters might not be a simple linear relationship,
Fig. 3 Effect of CP1 on an acetylcholinesterase (AChE) enzyme
activity in hippocampus. (n = 8/group) ***p-value < .001; compared to
vehicle + ACSF group. #, ##p-value < .05 and .01 respectively;
compared to vehicle + AF64A group
Fig. 4 Effect of CP1 on the level of ERK1/2 and pERK1/2 in hippocampus. a Western blots for phospho-(p)-ERK1/2 and total ERK1/2 b the ratio of
phospho-ERK to total ERK band densities (n = 8/group). ***p-value < .001; compared to vehicle + ACSF group. #, ##, ###p-value < .05, .01 and .001
respectively; compared to vehicle + AF64A group
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and the active ingredient may also exert the beneficial
effect indirectly via other signal transduction process
such as ERK1/2. Since no significant differences among
doses were observed, we suggested that the medium
dose would be the most appropriate dose for application
based on its benefit in all parameters, including the
effect on the ERK signal pathway. Since this dose could
effectively exert a positive modulation effect on multiple
targets, it could also provide a greater benefit. In
addition, the medium dose also provides a lower risk for
toxicity than the high dose of CP1.
A limitation of this study is that all ingredients of the
combined extract are not determined. Based on previous
studies, it has been demonstrated that gingerol [45] and
quercetin [46] exert protective effects against oxidative
stress-related neurodegeneration. Therefore, we mea-
sured the concentrations of the mentioned substances in
the combined extract. Since both substances were also
found in the combined extract, and the observed effect
was similar to the effect of both substances, we sug-
gested that they might be partly responsible for the neu-
roprotective effect of CP1 in this study. In addition to
the direct effect of both substances mentioned earlier,
interaction effects of various ingredients, including the
interaction of both ingredients and the effect of other
constituents, are still possible. However, further investi-
gations are necessary to provide better understanding
concerning the possible active ingredients.
Conclusion
CP1, the combined extract of C. rotundus and Z. offici-
nale, is a potential supplement to improve neurodegenera-
tion and memory impairment. The possible mechanism
for its beneficial effects may be through improving oxida-
tive stress status, which in turn would increase pERK1/2
in the hippocampus, leading to improvement in memory
impairment. In addition, CP1 can also suppress AChE
activity in the hippocampus, giving rise to increased avail-
able ACh and increased function of ACh via the nicotinic
receptor, resulting in enhanced memory performance.
However, further studies are necessary to investigate the
precise active ingredients and subchronic toxicity of CP1
and its interaction with drugs that are commonly used in
elderly patients to assure safe consumption.
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